HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nicolas Chapuis Selected Research
Nicolas Chapuis Research Topics
Disease
17
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 08/2007
12
Neoplasms (Cancer)
01/2022 - 08/2009
5
COVID-19
06/2022 - 01/2020
4
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022 - 03/2016
2
Leukemia
01/2020 - 06/2013
2
Anemia
01/2019 - 03/2016
1
Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2022
1
Oncogene Addiction
01/2022
1
Hematologic Neoplasms (Hematological Malignancy)
01/2022
1
Critical Illness (Critically Ill)
01/2022
1
Acute Promyelocytic Leukemia
01/2022
1
Philadelphia Chromosome
12/2021
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2021
1
Pathologic Neovascularization
11/2021
1
Multiple Myeloma
08/2021
1
Overweight
07/2021
1
Inflammation (Inflammations)
07/2021
1
Pneumonia (Pneumonitis)
01/2021
1
Lymphoma (Lymphomas)
01/2021
1
Melanoma (Melanoma, Malignant)
11/2016
1
Nerve Sheath Neoplasms (Nerve Sheath Neoplasm)
06/2016
1
Plexiform Neurofibroma
06/2016
1
Neurofibrosarcoma (MPNST)
06/2016
1
Carcinoma (Carcinomatosis)
11/2015
1
Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
06/2013
1
Leukopenia
08/2012
1
Ascites
08/2012
1
Pleural Effusion (Pleural Effusions)
08/2012
1
Edema (Dropsy)
08/2012
1
Thrombocytopenia (Thrombopenia)
08/2012
1
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2012
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2012
Drug/Important Bio-Agent (IBA)
7
Mechanistic Target of Rapamycin Complex 1
IBA
06/2016 - 01/2008
6
TOR Serine-Threonine Kinases
IBA
11/2013 - 01/2008
5
Proteins (Proteins, Gene)
FDA Link
01/2022 - 08/2009
3
Leukocyte L1 Antigen Complex (Calgranulin)
IBA
06/2022 - 01/2020
3
Pharmaceutical Preparations
IBA
01/2021 - 07/2011
3
Sirolimus (Rapamycin)
FDA Link
06/2016 - 08/2009
3
Phosphatidylinositols (Phosphatidylinositol)
IBA
04/2012 - 08/2007
3
MTOR Inhibitors
IBA
04/2012 - 12/2009
2
Biomarkers (Surrogate Marker)
IBA
06/2022 - 07/2021
2
Monoclonal Antibodies
IBA
08/2021 - 01/2021
2
Hematinics
IBA
01/2019 - 03/2016
2
Glutamine (L-Glutamine)
FDA Link
09/2015 - 11/2013
2
Metformin (Glucophage)
FDA Link
Generic
07/2011 - 11/2010
2
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2008 - 08/2007
1
Alarmins
IBA
06/2022
1
trametinib
IBA
01/2022
1
eprenetapopt
IBA
01/2022
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2022
1
Biological Products
IBA
01/2022
1
Etoposide (VP 16)
FDA Link
Generic
01/2022
1
ponatinib
IBA
12/2021
1
asciminib
IBA
12/2021
1
Fibrin Fibrinogen Degradation Products
IBA
11/2021
1
Cytokines
IBA
11/2021
1
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
11/2021
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
11/2021
1
Interleukin-1 (Interleukin 1)
IBA
11/2021
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2021
1
Interleukin-6 (Interleukin 6)
IBA
07/2021
1
ischemia-modified albumin
IBA
07/2021
1
Sulfhydryl Compounds (Thiols)
IBA
07/2021
1
Advanced Oxidation Protein Products (AOPP)
IBA
07/2021
1
Brentuximab Vedotin
IBA
01/2021
1
Interferon-gamma (Interferon, gamma)
IBA
01/2021
1
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
01/2021
1
1- ((2- ((2- chloropyridin- 4yl)amino)- 4'- (cyclopropylmethyl)- (4,5'- bipyrimidin)- 2'- yl)amino)- 2- methylpropan- 2- ol
IBA
10/2020
1
Iron
IBA
01/2020
1
RNA (Ribonucleic Acid)
IBA
01/2020
1
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2020
1
Ferritins (Ferritin)
IBA
01/2019
1
Hepcidins
IBA
01/2019
1
Erythropoietin
FDA Link
01/2019
1
Hemoglobins (Hemoglobin)
IBA
01/2019
1
guanosine 5'-monophosphorothioate
IBA
01/2017
1
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
11/2016
1
Vemurafenib
IBA
11/2016
1
Proliferating Cell Nuclear Antigen (PCNA)
IBA
10/2016
1
Adenosine Triphosphate (ATP)
IBA
06/2016
1
Mechanistic Target of Rapamycin Complex 2
IBA
06/2016
1
(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanol
IBA
06/2016
1
Immunoglobulin G (IgG)
IBA
03/2016
1
APG101
IBA
03/2016
1
1-dodecylpyridoxal (PLD)
IBA
11/2015
1
liposomal doxorubicin (Doxil)
FDA Link
11/2015
1
Sorafenib (BAY 43-9006)
FDA Link
06/2013
1
Dasatinib (BMS 354825)
FDA Link
08/2012
1
Cytostatic Agents
IBA
04/2012
1
romiplostim
FDA Link
01/2012
1
Thrombopoietin Receptors
IBA
01/2012
1
AICA ribonucleotide (ZMP)
IBA
07/2011
1
Biguanides
IBA
11/2010
1
Transcription Factors (Transcription Factor)
IBA
11/2010
1
Phosphotransferases (Kinase)
IBA
11/2010
Therapy/Procedure
11
Therapeutics
01/2022 - 10/2008
2
Drug Therapy (Chemotherapy)
12/2020 - 12/2011
1
Mechanical Ventilators (Ventilator)
01/2021
1
Heterologous Transplantation (Xenotransplantation)
11/2013
1
Salvage Therapy
01/2012